Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term features. Found 15 abstracts

Cook JR, Goldman B, Tubbs RR, Rimsza L, Leblanc M, Stiff P, Fisher R. Clinical Significance of MYC Expression and/or "High-grade" Morphology in Non-Burkitt, Diffuse Aggressive B-cell Lymphomas A SWOG S9704 Correlative Study. American Journal of Surgical Pathology. 2014 Apr;38(4):494-501.   PMCID: PMC 3955880
Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen DY, Greenberg R, Smaldone M, Kutikov A. Coexisting Hybrid Malignancy in a Solitary Sporadic Solid Benign Renal Mass: Implications for Treating Patients Following Renal Biopsy. Journal of Urology. 2014 Feb;191(2):296-300.   PMCID: PMC4083459
Foss F, Horwitz SM, Coiffier B, Bartlett N, Popplewell L, Pro B, Pinter-Brown LC, Shustov A, Furman RR, Haioun C, Koutsoukos T, O'Connor OA. Pralatrexate Is an Effective Treatment for Relapsed or Refractory Transformed Mycosis Fungoides: A Subgroup Efficacy Analysis From the PROPEL Study. Clinical Lymphoma Myeloma & Leukemia. 2012 Aug;12(4):238-43.   PMCID: *
Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, Sinilnikova OM, Southey MC, Terry MB, Goldgar D, O'Malley F, John EM, Janavicius R, Tihomirova L, Hansen TV, Nielsen FC, Osorio A, Stavropoulou A, Benitez J, Manoukian S, Peissel B, Barile M, Volorio S, Pasini B, Dolcetti R, Putignano AL, Ottini L, Radice P, Hamann U, Rashid MU, Hogervorst FB, Kriege M, van der Luijt RB, Peock S, Frost D, Evans DG, Brewer C, Walker L, Rogers MT, Side LE, Houghton C, Weaver J, Godwin AK, Schmutzler RK, Wappenschmidt B, Meindl A, Kast K, Arnold N, Niederacher D, Sutter C, Deissler H, Gadzicki D, Preisler-Adams S, Varon-Mateeva R, Schonbuchner I, Gevensleben H, Stoppa-Lyonnet D, Belotti M, Barjhoux L, Isaacs C, Peshkin BN, Caldes T, de la Hoya M, Canadas C, Heikkinen T, Heikkila P, Aittomaki K, Blanco I, Lazaro C, Brunet J, Agnarsson BA, Arason A, Barkardottir RB, Dumont M, Simard J, Montagna M, Agata S, D'Andrea E, Yan M, Fox S, Rebbeck TR, Rubinstein W, Tung N, Garber JE, Wang XS, Fredericksen Z, Pankratz VS, Lindor NM, Szabo C, Offit K, Sakr R, Gaudet MM, Singer CF, Tea MK, Rappaport C, Mai PL, Greene MH, Sokolenko A, Imyanitov E, Toland AE, Senter L, Sweet K, Thomassen M, Gerdes AM, Kruse T, Caligo M, Aretini P, Rantala J, von Wachenfeld A, Henriksson K, Steele L, Neuhausen SL, Nussbaum R, Beattie M, Odunsi K, Sucheston L, Gayther SA, Nathanson K, Gross J, Walsh C, Karlan B, Chenevix-Trench G, Easton DF, Antoniou AC. Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology Biomarkers & Prevention. 2012 Jan;21(1):134-47.   PMCID: PMC3272407
Skarbnik AP, Smith MR. Brentuximab vedotin in anaplastic large cell lymphoma. Expert Opinion on Biological Therapy. 2012 May;12(5):633-9.   PMCID: *
Solin LJ, Gray R, Goldstein LJ, Recht A, Baehner FL, Shak S, Badve S, Perez EA, Shulman LN, Martino S, Davidson NE, Sledge GW, Sparano JA. Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study. Breast Cancer Research and Treatment. 2012 Jul;134(2):683-92.   PMCID: PMC 3552372
Volpe A, Finelli A, Gill IS, Jewett MA, Martignoni G, Polascik TJ, Remzi M, Uzzo RG. Rationale for Percutaneous Biopsy and Histologic Characterisation of Renal Tumours. European Urology. 2012 Sep;62(3):491-504.   PMCID: not NIH funded
Alam N, Gustafson KS, Ladanyi M, Zakowski MF, Kapoor A, Truskinovsky AM, Dudek AZ. Small-Cell Carcinoma With an Epidermal Growth Factor Receptor Mutation in a Never-Smoker With Gefitinib-Responsive Adenocarcinoma of the Lung. Clinical lung cancer. 2010 Sep;11(5):E1-E4.   PMCID: no NIH funding
Brooks JD, Cairns P, Shore RE, Klein CB, Wirgin I, Afanasyeva Y, Zeleniuch-Jacquotte A. DNA methylation in pre-diagnostic serum samples of breast cancer cases: Results of a nested case-control study. Cancer Epidemiology. 2010 Dec;34(6):717-23.   PMCID: PMC2956002
Hsu TC, Chang CH, Lin MC, Liu ST, Yen TJ, Tsay GJ. Anti-CENP-H antibodies in patients with Sjogren's syndrome. Rheumatology International. 2006 Feb;26(4):298-303.
Longacre TA, Ennis M, Quenneville LA, Bane AL, Bleiweiss IJ, Carter BA, Catelano E, Hendrickson MR, Hibshoosh H, Layfield LJ, Memeo L, Wu H, O'Malley FP. Interobserver agreement and reproducibility in classification of invasive breast carcinoma: an NCI breast cancer family registry study. Modern Pathology. 2006 Feb;19(2):195-207.
Young NA, T Moriarty A, Walsh MK, Wang E, Wilbur DC. The potential for failure in gynecologic regulatory proficiency testing with current slide validation criteria - Results from the College of American Pathologists Interlaboratory Comparison in Gynecologic Cytology Program. Archives of pathology & laboratory medicine. 2006 Aug;130(8):1114-8.
Al-Saleem T, Cairns P, Dulaimi EA, Feder M, Testa JR, Uzzo RG. The genetics of renal oncocytosis: a possible model for neoplastic progression. Cancer Genetics and Cytogenetics. 2004 Jul;152(1):23-8.
Longo DL, Duffey PL, Jaffe ES, Raffeld M, Hubbard SM, Fisher RI, Wittes RE, Devita VT, Young RC. Diffuse Small Noncleaved-Cell, Non-Burkitts Lymphoma in Adults - a High-Grade Lymphoma Responsive to Promace-Based Combination Chemotherapy. Journal of Clinical Oncology. 1994 Oct;12(10):2153-9.
Engstrom PF. Predictors of Future Breast-Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 1993 Jan;2(1):1-2.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term features

features carcinoma non-hodgkins-lymphoma patterns kidney mutations multicenter pathology cell carcinoma women prednisone clinical management lymphoma Pathology locoregional recurrence crest syndrome trial hybridization oncocytoma 10-deazaaminopterin prediction ki-1 lymphoma utility well single-institution adenoma EGFR mutation tumor subtypes Medical Laboratory Technology unclassifiable with features intermediate between DLBCL and BL MYC plasma cancer subtypes DNA methylation cervicovaginal cytology children therapy germline risks surveillance accuracy receptor conserving therapy immunohistochemistry cell-carcinoma brca1 percutaneous biopsy Polymerase chain reaction aberrant methylation consistency doxorubicin t-cell lymphoma invasive breast cancer interobserver reproducibility-familial breast cancer-breast survival ALK ALCL-anaplastic large cell lymphoma-antibody-drug conjugate-brentuximab vedotin-CD30-MMAE-non-Hodgkin lymphoma-SGN-35-T-cell lymphoma needle core biopsy rituximab plus cyclophosphamide tumors fine-needle-aspiration oxyphilic risk Research & Experimental Medicine Serum Breast cancer prognosis L858R aggressive lymphomas renal cell competing rar-beta core biopsy squamous intraepithelial lesion computed-tomography anticentromere antibodies gene promoter hypermethylation cervical smears distinct united-states medullary carcinoma anti-CENP-H antibody proteins cancer expression gene-mutations active surveillance QMSP immunohistochemical markers Renal mass Needle core biopsy-Renal cell carcinoma-Diagnosis-Prognosis-Molecular markers-Cytogenetic markers kinase variability tumor dna phenotype diagnostic-accuracy performance anti-centromere antibody LREA disease vincristine diffuse large B-cell lymphoma sera estrogen-receptor status experience relapse diagnosis classification bcl2 Early detection centromere-kinetochore regimen radiofrequency ablation papanicolaou smears progesterone-receptor Breast conservation treatment Early stage breast carcinoma-Radiation treatment-21-Gene recurrence score-Local recurrence-Local-regional recurrence failure egfr mutation estrogen-receptor interobserver variability lesions malignant- ovarian cancer family registry Efficacy Antifolate-Relapsed-Refractory peripheral T-cell lymphoma-Safety-Transformed mycosis fungoides childhood kappa 1995 bruin pc-leukemia-v9-p1620 Sjogren's syndrome autoantigens pathological criteria cell-free dna response imaging-guided biopsy variants rearrangements B-cell lymphoma hogg-dube-syndrome clinicopathological cancers oncocytomatosis systemic-sclerosis frankfurt-munster group in-situ hybridization
Last updated on Friday, January 03, 2020